Antibody microarray analysis holds promise for increasing accuracy of breast cancer screening
Not exact matches
The
analysis of doxorubicin resistance in human breast cancer cells using
antibody microarrays.
Microarray Analysis: Test antibody specificity was evaulated using CDI HuProt ™ Human Proteome Microarray and subsequently analyzed with GenePix Pro Image Acquisition and Analysis Software, the benchmark tool for the acquisition and analysis of microarr
Microarray Analysis: Test antibody specificity was evaulated using CDI HuProt ™ Human Proteome Microarray and subsequently analyzed with GenePix Pro Image Acquisition and Analysis Software, the benchmark tool for the acquisition and analysis of microarray
Analysis: Test
antibody specificity was evaulated using CDI HuProt ™ Human Proteome
Microarray and subsequently analyzed with GenePix Pro Image Acquisition and Analysis Software, the benchmark tool for the acquisition and analysis of microarr
Microarray and subsequently analyzed with GenePix Pro Image Acquisition and
Analysis Software, the benchmark tool for the acquisition and analysis of microarray
Analysis Software, the benchmark tool for the acquisition and
analysis of microarray
analysis of
microarraymicroarray images.
Microarray Analysis: Test antibody specificity was evaulated using CDI HuProt ™ Human Proteome Microarray (~ 75 % of the human proteome) and subseqently analyzed with GenePix Pro Image Acquisition and Analysis Software, the benchmark tool for the acquisition and analysis of microarr
Microarray Analysis: Test antibody specificity was evaulated using CDI HuProt ™ Human Proteome Microarray (~ 75 % of the human proteome) and subseqently analyzed with GenePix Pro Image Acquisition and Analysis Software, the benchmark tool for the acquisition and analysis of microarray
Analysis: Test
antibody specificity was evaulated using CDI HuProt ™ Human Proteome
Microarray (~ 75 % of the human proteome) and subseqently analyzed with GenePix Pro Image Acquisition and Analysis Software, the benchmark tool for the acquisition and analysis of microarr
Microarray (~ 75 % of the human proteome) and subseqently analyzed with GenePix Pro Image Acquisition and
Analysis Software, the benchmark tool for the acquisition and analysis of microarray
Analysis Software, the benchmark tool for the acquisition and
analysis of microarray
analysis of
microarraymicroarray images.
Microarray Analysis: Test antibody specificity was evaulated using CDI HuProt ™ Human Proteome Microarray (19,394 human proteins) and subseqently analyzed with GenePix Pro Image Acquisition and Analysis Software, the benchmark tool for the acquisition and analysis of microarr
Microarray Analysis: Test antibody specificity was evaulated using CDI HuProt ™ Human Proteome Microarray (19,394 human proteins) and subseqently analyzed with GenePix Pro Image Acquisition and Analysis Software, the benchmark tool for the acquisition and analysis of microarray
Analysis: Test
antibody specificity was evaulated using CDI HuProt ™ Human Proteome
Microarray (19,394 human proteins) and subseqently analyzed with GenePix Pro Image Acquisition and Analysis Software, the benchmark tool for the acquisition and analysis of microarr
Microarray (19,394 human proteins) and subseqently analyzed with GenePix Pro Image Acquisition and
Analysis Software, the benchmark tool for the acquisition and analysis of microarray
Analysis Software, the benchmark tool for the acquisition and
analysis of microarray
analysis of
microarraymicroarray images.
Antibody Cross-Reactivity Testing Using the HuProt ™ Human Proteome
Microarray Analysis of several commercially available
antibodies against nearly 75 % of the human proteome.